Biodesix annual operating margin
2019
2020
2021
2022
2023
2024
2025
Biodesix's operating margin was −31.50% for fiscal 2025.
View full Biodesix company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −31.50% | +16.87 pp |
| 2024 | 2024-12-31 | −48.37% | +35.85 pp |
| 2023 | 2023-12-31 | −84.22% | +48.16 pp |
| 2022 | 2022-12-31 | −132.39% | −57.27 pp |
| 2021 | 2021-12-31 | −75.11% | −24.77 pp |
| 2020 | 2020-12-31 | −50.34% | +58.57 pp |
| 2019 | 2019-12-31 | −108.92% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −20.06% | +28.49 pp |
| Q1 2026 | 2026-03-31 | −24.27% | +26.61 pp |
| Q4 2025 | 2025-12-31 | −6.84% | +25.71 pp |
| Q3 2025 | 2025-09-30 | −32.39% | +14.94 pp |
| Q2 2025 | 2025-06-30 | −48.55% | −2.60 pp |
| Q1 2025 | 2025-03-31 | −50.87% | +23.50 pp |
| Q4 2024 | 2024-12-31 | −32.55% | +14.29 pp |
| Q3 2024 | 2024-09-30 | −47.33% | +5.83 pp |
| Q2 2024 | 2024-06-30 | −45.95% | +46.09 pp |
| Q1 2024 | 2024-03-31 | −74.38% | +106.42 pp |
| Q4 2023 | 2023-12-31 | −46.84% | +97.75 pp |
| Q3 2023 | 2023-09-30 | −53.16% | +42.36 pp |
| Q2 2023 | 2023-06-30 | −92.04% | +14.13 pp |
| Q1 2023 | 2023-03-31 | −180.80% | +40.05 pp |
| Q4 2022 | 2022-12-31 | −144.58% | +17.09 pp |
| Q3 2022 | 2022-09-30 | −95.53% | +104.92 pp |
| Q2 2022 | 2022-06-30 | −106.17% | −17.09 pp |
| Q1 2022 | 2022-03-31 | −220.85% | −201.50 pp |
| Q4 2021 | 2021-12-31 | −161.67% | −151.85 pp |
| Q3 2021 | 2021-09-30 | −200.44% | −132.57 pp |
| Q2 2021 | 2021-06-30 | −89.08% | +43.48 pp |
| Q1 2021 | 2021-03-31 | −19.34% | +145.93 pp |
| Q4 2020 | 2020-12-31 | −9.82% | +219.21 pp |
| Q3 2020 | 2020-09-30 | −67.88% | — |
| Q2 2020 | 2020-06-30 | −132.55% | — |
| Q1 2020 | 2020-03-31 | −165.27% | — |
| Q3 2019 | 2019-09-30 | −229.02% | — |
Over the last five reported fiscal years, Biodesix's operating margin increased from −50.34% to −31.50%, a change of +18.85 percentage points. The latest reported quarter, Q2 2026, shows −20.06%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodesix filings at SEC.gov ↗